Cargando…
DCD Liver Grafts Can Safely Be Used for Recipients With Grade I–II Portal Vein Thrombosis: A Multicenter Analysis
With donation after circulatory death (DCD) liver transplantation (LT), the goal of the recipient implantation procedure is to minimize surgical complexity to avoid a tenuous environment for an already marginal graft. The presence of portal vein thrombosis (PVT) at the time of LT adds surgical compl...
Autores principales: | Mercado, Lydia A., Bhangu, Harpreet K., Calderon, Esteban, Mathur, Amit K., Aqel, Bashar, Musto, Kaitlyn R., Watt, Kymberly D., Rosen, Charles B., Bolan, Candice, LeGout, Jordan D., Taner, C. Burcin, Harnois, Denise M., Croome, Kristopher P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553382/ https://www.ncbi.nlm.nih.gov/pubmed/36246002 http://dx.doi.org/10.1097/TXD.0000000000001392 |
Ejemplares similares
-
The Changing Landscapes in DCD Liver Transplantation
por: Croome, Kristopher P., et al.
Publicado: (2020) -
Comparison of Supraceliac and Infrarenal Aortic Conduits in Liver Transplantation: Is There a Difference in Patency and Postoperative Renal Dysfunction?
por: Livingston, David, et al.
Publicado: (2019) -
Early Allograft Dysfunction Is Associated With Higher Risk of Renal Nonrecovery After Liver Transplantation
por: Wadei, Hani M., et al.
Publicado: (2018) -
Selecting DCD Recipients Using Predictive Indices
por: Ganni, Saif, et al.
Publicado: (2023) -
Direct-Acting Antiviral Therapy in Liver Transplant Patients With Hepatocellular Carcinoma and Hepatitis C
por: Tse, Chung Sang, et al.
Publicado: (2020)